Infectious disease: Fighting influenza B
Nature Reviews Drug Discovery 16, 828 (2017).
doi:10.1038/nrd.2017.234
Author: Sarah Crunkhorn
The use of broadly neutralizing antibodies against the influenza viral surface glycoprotein haemagglutinin (HA) represents a promising therapeutic approach. In mice, Shen et al. implemented several immunization regimens to induce cross-reactive antibodies against highly conserved epitopes in the HA protein of influenza B. A
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research